Investigational gefurulimab met its primary efficacy endpoint in adults with anti-acetylcholine receptor (AChR) ...

The Centers for Medicare & Medicaid Services (CMS) on Friday finalized its annual physician fee schedule for 2026, giving ...

Three popular GLP-1 receptor agonists carried similar risks for serious gastrointestinal (GI) events among adults with type 2 ...

Yet, the expectation from all of this healthcare-generated data is that we in primary care, primarily, will be the ones reviewing all of it, dealing with it, getting back to our patients about it, ...

Physical activity has been identified as a modifiable risk factor for dementia, but its relationship with Alzheimer's ...

Involuntary movements caused by tardive dyskinesia (TD), a movement disorder induced by dopamine-receptor antagonists like ...

Bank A was the largest, with 2,554 encounters (average 30.1 eggs retrieved), followed by Bank B with 2,269 (average 28.0 eggs ...

SAN FRANCISCO -- Two studies demonstrated the benefits of treating juvenile myasthenia gravis (MG) with newer drugs.